Scilex Holding Stock Probability of Future Stock Price Finishing Under 0.98
| SCLX Stock | 0.59 0.02 3.51% |
Scilex |
Scilex Holding Target Price Odds to finish below 0.98
The tendency of Scilex Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under 0.98 after 90 days |
| 0.59 | 90 days | 0.98 | about 79.42 |
Based on a normal probability distribution, the odds of Scilex Holding to stay under 0.98 after 90 days from now is about 79.42 (This Scilex Holding probability density function shows the probability of Scilex Stock to fall within a particular range of prices over 90 days) . Probability of Scilex Holding price to stay between its current price of 0.59 and 0.98 at the end of the 90-day period is about 72.41 .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.63 . This usually implies as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Scilex Holding will likely underperform. Additionally Scilex Holding has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Scilex Holding Price Density |
| Price |
Predictive Modules for Scilex Holding
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Scilex Holding. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Scilex Holding Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Scilex Holding is not an exception. The market had few large corrections towards the Scilex Holding's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Scilex Holding, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Scilex Holding within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.98 | |
β | Beta against Dow Jones | 2.63 | |
σ | Overall volatility | 0.17 | |
Ir | Information ratio | -0.12 |
Scilex Holding Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Scilex Holding for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Scilex Holding can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Scilex Holding generated a negative expected return over the last 90 days | |
| Scilex Holding has high historical volatility and very poor performance | |
| Scilex Holding has some characteristics of a very speculative penny stock | |
| Scilex Holding has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 46.74 M. Net Loss for the year was (114.33 M) with profit before overhead, payroll, taxes, and interest of 27.24 M. | |
| Scilex Holding generates negative cash flow from operations | |
| About 33.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from globenewswire.com: Scilex Bio, a Controlling Interest of Joint Venture by Scilex Holding Company, Reports Phase 2 Trial for Obesity Currently Enrolling with U.S. Patient Cohort to be Added in 2025. Scilex Bio Reports Positive Results from the Recently Completed Phase 1 Trials Conducted by NeuroBiogen for KDS2010, a Novel Oral Tablet Recently Synthesized Potent, Selective, and Reversible Monoamine Oxidase B inhibitor |
Scilex Holding Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Scilex Stock often depends not only on the future outlook of the current and potential Scilex Holding's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Scilex Holding's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 130.3 M | |
| Cash And Short Term Investments | 3.9 M |
Scilex Holding Technical Analysis
Scilex Holding's future price can be derived by breaking down and analyzing its technical indicators over time. Scilex Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Scilex Holding. In general, you should focus on analyzing Scilex Stock price patterns and their correlations with different microeconomic environments and drivers.
Scilex Holding Predictive Forecast Models
Scilex Holding's time-series forecasting models is one of many Scilex Holding's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Scilex Holding's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Scilex Holding
Checking the ongoing alerts about Scilex Holding for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Scilex Holding help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Scilex Holding generated a negative expected return over the last 90 days | |
| Scilex Holding has high historical volatility and very poor performance | |
| Scilex Holding has some characteristics of a very speculative penny stock | |
| Scilex Holding has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 46.74 M. Net Loss for the year was (114.33 M) with profit before overhead, payroll, taxes, and interest of 27.24 M. | |
| Scilex Holding generates negative cash flow from operations | |
| About 33.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from globenewswire.com: Scilex Bio, a Controlling Interest of Joint Venture by Scilex Holding Company, Reports Phase 2 Trial for Obesity Currently Enrolling with U.S. Patient Cohort to be Added in 2025. Scilex Bio Reports Positive Results from the Recently Completed Phase 1 Trials Conducted by NeuroBiogen for KDS2010, a Novel Oral Tablet Recently Synthesized Potent, Selective, and Reversible Monoamine Oxidase B inhibitor |
Additional Tools for Scilex Stock Analysis
When running Scilex Holding's price analysis, check to measure Scilex Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scilex Holding is operating at the current time. Most of Scilex Holding's value examination focuses on studying past and present price action to predict the probability of Scilex Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scilex Holding's price. Additionally, you may evaluate how the addition of Scilex Holding to your portfolios can decrease your overall portfolio volatility.